Pre­clin­i­cal biotech Metageno­mi prices $94M IPO at low end of pro­posed range

The bounc­er is let­ting a pre­clin­i­cal biotech en­ter the IPO club Thurs­day night.

Yes, the time­stamp is 2024. A pre­clin­i­cal Nas­daq of­fer­ing sounds like a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.